Private Capital Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Private Capital Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,083	Closed	-$97K	–	2140
2022 Q1	$97K	Hold	1,083	–	–	0.02%	407
2021 Q4	$121K	Hold	1,083	–	–	0.03%	368
2021 Q3	$136K	Hold	1,083	–	–	0.03%	321
2021 Q2	$147K	Hold	1,083	–	–	0.03%	288
2021 Q1	$147K	Hold	1,083	–	–	0.04%	279
2020 Q4	$153K	Hold	1,083	–	–	0.03%	373
2020 Q3	$121K	Hold	1,083	–	–	0.03%	399
2020 Q2	$121K	Hold	1,083	–	–	0.03%	391
2020 Q1	$84K	Hold	1,083	–	–	0.02%	453
2019 Q4	$103K	Sell	1,083 -3,360	-76%	-$291K	0.02%	442
2019 Q3	$339K	Sell	4,443 -2,150	-33%	-$179K	0.06%	186
2019 Q2	$628K	Buy	6,593 +1,295	+24%	+$110K	0.14%	106
2019 Q1	$480K	Sell	5,298 -258	-5%	-$21.9K	0.09%	143
2018 Q4	$399K	Sell	5,556 -1,017	-15%	-$81.9K	0.09%	149
2018 Q3	$630K	Sell	6,573 -20	-0.3%	-$1.94K	0.13%	122
2018 Q2	$627K	Sell	6,593 -500	-7%	-$46K	0.14%	114
2018 Q1	$622K	Buy	7,093 +6,268	+760%	+$572K	0.14%	112
2017 Q4	$34K	Buy	+825	New	+$69.1K	0.01%	847

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Private Capital Group's XBI Position: Q2 2022 in Review

Private Capital Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2022, closing a stake of 1,083 shares — an estimated $97K sold.

Private Capital Group first reported a position in XBI in Q4 2017 and held it in 18 quarters. The position peaked at $630K in Q3 2018. 704 funds tracked by Wall St. Rank hold XBI as of Q2 2022.

Private Capital Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2022 after selling out during the quarter.
Private Capital Group sold 1,083 State Street SPDR S&P Biotech ETF shares in Q2 2022, an estimated $97K.
Private Capital Group first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and held it in 18 quarters.
Private Capital Group's State Street SPDR S&P Biotech ETF position peaked at $630K in Q3 2018.
704 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.